102-46-5

Basic information

• Product Name: 3,4-Dimethylbenzyl chloride
• Synonyms: 4-(chloromethyl)-1,2-dimethyl-benzen;4-(Chloromethyl)-1,2-dimethylbenzene;Benzene, 1-(chloromethyl)-3,4-dimethyl-;4-CHLOROMETHYL-O-XYLENE;AKOS BBS-00003954;1-CHLOROMETHYL-3,4-DIMETHYLBENZENE;3,4-DIMETHYLBENZYL CHLORIDE;3,4-DIMETHYLBENZYL CHLORIDE, TECH., 60%
• CAS NO: 102-46-5
• Molecular Formula: C₉H₁₁Cl
• Molecular Weight: 154.64
• EINECS: 203-032-5
• Product Categories: Aromatic Halides (substituted);Benzenes;Aryl;C9 to C12;Halogenated Hydrocarbons
• Mol File: 102-46-5.mol
• Article Data: 16

Chemical Properties

• Melting Point: -43.35°C (estimate)
• Boiling Point: 116-117 °C24 mm Hg(lit.)
• Flash Point: 205 °F
• Appearance: Clear colorless to pale yellow/Liquid
• Density: 1.056 g/mL at 25 °C(lit.)
• Vapor Pressure: 0.136mmHg at 25°C
• Refractive Index: n20/D 1.54(lit.)
• Storage Temp.: Keep in dark place,Sealed in dry,Room Temperature
• CAS DataBase Reference: 3,4-Dimethylbenzyl chloride(CAS DataBase Reference)
• NIST Chemistry Reference: 3,4-Dimethylbenzyl chloride(102-46-5)
• EPA Substance Registry System: 3,4-Dimethylbenzyl chloride(102-46-5)

Safety Data

• Hazard Codes: C,Xi
• Statements: 34-36/37
• Safety Statements: 26-36/37/39-45
• RIDADR: UN 3265 8/PG 2
• WGK Germany: 3
• HazardClass: 8
• PackingGroup: III
• Hazardous Substances Data: 102-46-5(Hazardous Substances Data)

Usage

Synthesis Reference(s)

Journal of Medicinal Chemistry, 32, p. 1757, 1989 DOI: 10.1021/jm00128a016

InChI:InChI=1/C9H11Cl/c1-7-3-4-9(6-10)5-8(7)2/h3-5H,6H2,1-2H3

Upstream product

• 50-00-0 formaldehyd 
• 95-47-6 o-xylene 
• 107-30-2 chloromethyl methyl ether 
• 64-19-7 acetic acid 
• 7647-01-0 hydrogenchloride 
• 95-63-6 1,2,4-Trimethylbenzene 
• 123-63-7 paracetaldehyde 
• 583-71-1 4-bromo-o-xylene 
• 619-04-5 3,4-dimethylbenzoic acid 
• 38404-42-1 methyl 3,4-dimethylbenzoate 
• 110-88-3 1,3,5-Trioxan 
• 6966-10-5 3,4-dimethylbenzyl alcohol 

Downstream Products

• 33801-40-0 Benzyl-phosphonodithioic acid S-(3,4-dimethyl-benzyl) ester O-methyl ester 
• 41594-21-2 3,4-Dimethylbenzylcystein 
• 36229-34-2 2,4-Dimethyl-1,5-di-(3,4-dimethylphenyl)-2,4-pentandiol 
• 3020-06-2 3,4-dimethylphenylacetonitrile 
• 52803-86-8 Methyl-2-(3.4-dimethylbenzyloxy)benzoat 
• 4496-95-1 (3,4-dimethyl-phenyl)-methanethiol 
• 138376-58-6 1-(3,4-Dimethyl-phenyl)-butan-2-one 
• 138376-60-0 Propionic acid 3,4-dimethyl-benzyl ester 
• 138376-48-4 Propionic acid 1-[1-(3,4-dimethyl-phenyl)-meth-(E)-ylidene]-propyl ester 
• 151409-80-2 1-(3,4-Dimethyl-benzyl)-1H-indole-3-carbaldehyde 
• 203069-99-2 1-(3,4-Dimethyl-benzyl)-1H-benzotriazole 
• 17283-14-6 3,4-dimethylphenethylamine 
• 68119-92-6 1-(3,4-dimethyl-benzyl)-1H-imidazole-4,5-dicarbonitrile 
• 1221432-81-0 1,6-dimethyl-3-methylene-6-(propa-1,2-dienyl)cyclohexa-1,4-diene 

Relevant articles and documents

Improved preparation of 3,3′,4,4′-tetramethyldiphenylethane by self coupling reaciton in aqueous media

In this article, 3,3′,4,4′-tetramethyldiphenylethane was obtained in 86.5% total yield by self coupling reaction of 3,4-dimethylbenzyl chloride catalyzed by Cu/Cu/2/Cl/2//PEG-600 and promoted by iron in aqueous media and the starting

Mechanism of solvolysis of substituted benzyl chlorides in aqueous ethanol

The mechanism of solvolyses of activated ortho-, meta- and para-substituted benzyl chlorides in aqueous ethanol has been studied by using the Hammett-Brown and Yukawa-Tsuno treatments as well as by correlating logarithms of solvolysis rate constants with relative stabilities of corresponding benzyl carbocations in water calculated at the IEFPCM-M06–2X/6-311+G(3df,3pd) level of theory. Benzyl chlorides containing strong conjugative electron-donors in the para-position solvolyze by the SN1 mechanism, whereas other activated benzyl chlorides solvolyze by the SN2 mechanism via loose transition states.

BENZODIAZEPINONE COMPOUNDS AND METHODS OF TREATMENT USING SAME

The invention provides 1,4-benzodiazepinone compounds, pharmaceutical compositions, and methods of treating autoimmune disorders, chronic inflammatory disorders, and hyperproliferative disorders. For example, the 1,4-benzodiazepinone compounds and pharmaceutical compositions are contemplated to be useful for treating rheumatoid arthritis, graft-versus-host disease, inflammatory bowel disease, and the like.